Tirzepatide 60 mg

Tirzepatide is a peptide that acts as a dual agonist of the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors, two signaling pathways involved in metabolic regulation.

Research involving Tirzepatide has focused on its effects on glucose regulation, insulin secretion and sensitivity, appetite and satiety signaling, energy balance, lipid metabolism, and body-weight regulation.

Unlike single-receptor GLP-1 agonists, Tirzepatide simultaneously activates both GIP and GLP-1 receptors, making it an important compound for studying the interaction between incretin pathways and metabolic function.

Tirzepatide itself is also the active pharmaceutical ingredient in FDA-approved prescription medicines for type 2 diabetes and chronic weight management. Products sold specifically as research chemicals, however, should not be represented as those approved drug products.

For research use only. Not for human consumption.